Follow
Samiran Panda
Samiran Panda
ICMR-Dr AS Paintal Distinguished Scientist Chair
Verified email at icmr.gov.in
Title
Cited by
Cited by
Year
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ...
The Lancet 372 (9651), 1733-1745, 2008
17092008
SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
S Cherian, V Potdar, S Jadhav, P Yadav, N Gupta, M Das, P Rakshit, ...
Microorganisms 9 (7), 1542, 2021
796*2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
R Ella, KM Vadrevu, H Jogdand, S Prasad, S Reddy, V Sarangi, ...
The Lancet Infectious Diseases 21 (5), 637-646, 2021
4632021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ...
The Lancet 398 (10317), 2173-2184, 2021
3682021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a …
R Ella, S Reddy, H Jogdand, V Sarangi, B Ganneru, S Prasad, D Das, ...
The Lancet Infectious Diseases 21 (7), 950-961, 2021
3652021
Neutralization of variant under investigation B. 1.617. 1 with sera of BBV152 vaccinees
PD Yadav, GN Sapkal, P Abraham, R Ella, G Deshpande, DY Patil, ...
Clinical Infectious Diseases 74 (2), 366-368, 2022
2732022
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19
P Chatterjee, T Anand, KJ Singh, R Rasaily, R Singh, S Das, H Singh, ...
Indian Journal of Medical Research 151 (5), 459-467, 2020
2672020
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ...
The Lancet 399 (10339), 1941-1953, 2022
2562022
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ...
Indian Journal of Medical Research 152 (1-2), 48-60, 2020
2142020
Meth/amphetamine use and associated HIV: Implications for global policy and public health
L Degenhardt, B Mathers, M Guarinieri, S Panda, B Phillips, SA Strathdee, ...
International Journal of Drug Policy 21 (5), 347-358, 2010
2002010
SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
MV Murhekar, T Bhatnagar, S Selvaraju, V Saravanakumar, ...
The Lancet Global Health 9 (3), e257-e266, 2021
1952021
Rapid spread of HIV among injecting drug users in north-eastern states of India
S Sarkar, N Das, S Panda, TN Naik, K Sarkar, BC Singh, JM Ralte, ...
Bull Narc 45 (1), 91-105, 1993
1781993
Transmission of HIV from injecting drug users to their wives in India
S Panda, A Chatterjee, SK Bhattacharya, B Manna, PN Singh, S Sarkar, ...
International journal of STD & AIDS 11 (7), 468-473, 2000
1582000
Secondary infections in hospitalized COVID-19 patients: Indian experience
S Vijay, N Bansal, BK Rao, B Veeraraghavan, C Rodrigues, C Wattal, ...
Infection and drug resistance, 1893-1903, 2021
1552021
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2
GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ...
Journal of Travel Medicine 28 (4), taab051, 2021
1462021
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ...
International Journal of Infectious Diseases 108, 145-155, 2021
1352021
Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India
S Panda, MS Kumar, S Lokabiraman, K Jayashree, MC Satagopan, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (1), 9-15, 2005
1092005
Prevalence of HCV & HBV infection amongst HIV seropositive
MK Saha, S Chakrabarti, S Panda, TN Naik, B Manna, A Chatterjee, ...
Indian journal of medical research 111, 37-9, 2000
1092000
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
PD Yadav, GN Sapkal, R Ella, RR Sahay, DA Nyayanit, DY Patil, ...
Journal of Travel Medicine 28 (7), taab104, 2021
1042021
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ...
Nature communications 12 (1), 1386, 2021
972021
The system can't perform the operation now. Try again later.
Articles 1–20